Test Price
2,800 AED✅ Home Collection Available
ATXN3 Gene Spinocerebellar Ataxia Type 3 (SCA3) Genetic Test | UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance to support result interpretation by a board-certified geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) test analyzes the ATXN3 gene to detect the CAG trinucleotide repeat expansion responsible for autosomal dominant Spinocerebellar Ataxia Type 3 (SCA3 / Machado‑Joseph disease). Results are delivered within 3‑4 weeks with pre‑ and post‑test genetic counseling support.
| Feature | Our Test (NGS‑ATXN3) | Closest Alternative (Fragment Analysis) |
|---|---|---|
| Precision | Full‑gene coverage with exact repeat sizing and flanking variant detection | Repeat sizing only; may miss rare pathogenic variants |
| Methodology | NGS (Next‑Generation Sequencing) + orthogonal confirmation | PCR‑based fragment length analysis |
| Turnaround | 3‑4 weeks | 6‑8 weeks |
Physician Insight & Safety Protocols
“As a medical geneticist, I understand the profound implications a hereditary ataxia diagnosis carries for entire families. This test delivers definitive molecular evidence of SCA3, but it must be interpreted alongside a thorough neurological examination and detailed pedigree analysis. I strongly advise all patients to engage in pre‑test genetic counseling to grasp the autosomal dominant inheritance pattern and the potential impact on at‑risk relatives.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication & Safety Advisory
Do not alter or cease any prescribed treatments (particularly anti‑seizure medications, muscle relaxants, or antidepressants) without explicit approval from your treating physician. Abrupt discontinuation may lead to withdrawal symptoms or clinical deterioration.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals with an active severe infection, uncontrolled coagulopathy, or inability to provide informed consent without a legal guardian as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Red Flags (seek urgent care): Sudden deterioration in balance, speech, or swallowing; new‑onset seizures; or any signs of increased intracranial pressure (e.g., severe headache with vomiting). These symptoms may indicate an unrelated acute neurological event and should be evaluated immediately, irrespective of the scheduled test.
Patient FAQ & Clinical Guidance
1. What exactly does the ATXN3 NGS test detect?
This test identifies the abnormal CAG trinucleotide repeat expansion in the ATXN3 gene that definitively confirms a molecular diagnosis of Spinocerebellar Ataxia Type 3 (SCA3), also known as Machado‑Joseph disease. It provides precise repeat sizing and can detect rare flanking variants that other methods may miss.
2. How long does the result take and what happens after?
Results are reported within 3 to 4 weeks from sample receipt. Once available, a telephonic clinical guidance session with a DHA‑licensed geneticist is scheduled to explain the findings in the context of your family history and clinical picture.
3. Is this covered by insurance in the UAE?
We provide direct billing verification. Send your insurance card and Emirates ID via WhatsApp to +971 54 548 8731, and our team will confirm coverage under your neurological diagnostic benefits within one working day.
UAE Regulatory & Data Privacy Adherence
This test and our facility fully comply with:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
All genetic data is handled under strict confidentiality and used solely for diagnostic purposes. Our DHA Facility License Number is 1143.
Clinical & Logistical Metadata
| Test Name | ATXN3 Gene Spinocerebellar Ataxia Type 3 (SCA3) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with orthogonal confirmation |
| ICD-10-CM Code | G11.3 |
| LOINC Code | 47528-5 |
| DHA Facility License & Laboratory Address Invariants | DHA Facility License Number: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians